| 461 |
Mechanisms of metabolic changes induced by calcium entry blockers |
1990 |
| 462 |
Mechanisms of metabolic changes induced by calcium entry blockers |
1990 |
| 463 |
Modification of metabolic effects of tolbutamide by diltiazem |
1990 |
| 464 |
Modification of metabolic effects of tolbutamide by diltiazem |
1990 |
| 465 |
Modification of metabolic effects of tolbutamide by diltiazem |
1990 |
| 466 |
Possible CNS depressant effects of some newly synthesized quinazolinone derivatives. Bull. Pharm. |
1990 |
| 467 |
Possible CNS depressant effects of some newly synthesized quinazolinone derivatives. Bull. Pharm. |
1990 |
| 468 |
Possible CNS depressant effects of some newly synthesized quinazolinone derivatives. Bull. Pharm. |
1990 |
| 469 |
Some cardiovascular responses elicited by beta-adrenergic antagonists, calciumentry blockers and their combinations |
1990 |
| 470 |
Some cardiovascular responses elicited by beta-adrenergic antagonists, calciumentry blockers and their combinations |
1990 |